Boucher Kelley 4
4 · Apellis Pharmaceuticals, Inc. · Filed May 29, 2025
Insider Transaction Report
Form 4
Boucher Kelley
Chief People Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-05-28$16.80/sh+32,976$553,997→ 32,976 totalExercise: $16.80Exp: 2035-05-28→ Common Stock (32,976 underlying) - Award
Common Stock
2025-05-28+22,087→ 22,087 total
Footnotes (2)
- [F1]This restricted stock unit was granted on May 28, 2025. The restricted stock unit will fully vest on the first anniversary of the date of grant, subject to her continued service as an officer, or upon later termination of her service.
- [F2]This represents a stock option award granted May 28, 2025 that vests over a four-year period. 25% vests one year from grant date and the remaining 75% vests monthly thereafter subject to continued service.